25 XP   0   0   10

Bone Biologics Corp
Buy, Hold or Sell?

Let's analyse Bone Biologics Corp together

PenkeI guess you are interested in Bone Biologics Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bone Biologics Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bone Biologics Corp

I send you an email if I find something interesting about Bone Biologics Corp.

Quick analysis of Bone Biologics Corp (30 sec.)










What can you expect buying and holding a share of Bone Biologics Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$3.31
Expected worth in 1 year
$-0.15
How sure are you?
30.6%

+ What do you gain per year?

Total Gains per Share
$-3.46
Return On Investment
-162.4%

For what price can you sell your share?

Current Price per Share
$2.13
Expected price per share
$0 - $2.8601
How sure are you?
50%

1. Valuation of Bone Biologics Corp (5 min.)




Live pricePrice per Share (EOD)

$2.13

Intrinsic Value Per Share

$-139.86 - $-166.58

Total Value Per Share

$-136.56 - $-163.28

2. Growth of Bone Biologics Corp (5 min.)




Is Bone Biologics Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$2.9m$5.4m-$1.7m-44.9%

How much money is Bone Biologics Corp making?

Current yearPrevious yearGrowGrow %
Making money-$2.3m$173.5k-$2.5m-107.3%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Bone Biologics Corp (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#287 / 340

Most Revenue
#336 / 340

Most Profit
#183 / 340

Most Efficient
#116 / 340

What can you expect buying and holding a share of Bone Biologics Corp? (5 min.)

Welcome investor! Bone Biologics Corp's management wants to use your money to grow the business. In return you get a share of Bone Biologics Corp.

What can you expect buying and holding a share of Bone Biologics Corp?

First you should know what it really means to hold a share of Bone Biologics Corp. And how you can make/lose money.

Speculation

The Price per Share of Bone Biologics Corp is $2.13. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bone Biologics Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bone Biologics Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.31. Based on the TTM, the Book Value Change Per Share is $-0.86 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bone Biologics Corp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.76-82.8%-1.52-71.3%-1.06-49.6%-0.80-37.8%-1.86-87.1%
Usd Book Value Change Per Share2.1098.4%-0.86-40.6%-0.18-8.4%0.6530.7%0.094.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share2.1098.4%-0.86-40.6%-0.18-8.4%0.6530.7%0.094.3%
Usd Price Per Share4.52-1.73-1.36-0.99-1.11-
Price to Earnings Ratio-0.64--0.29--2.21--0.80--0.48-
Price-to-Total Gains Ratio2.16-0.64--1.11--0.90--0.48-
Price to Book Ratio1.37-0.57-0.81-0.29-0.06-
Price-to-Total Gains Ratio2.16-0.64--1.11--0.90--0.48-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.13
Number of shares469
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.860.65
Usd Total Gains Per Share-0.860.65
Gains per Quarter (469 shares)-405.55306.86
Gains per Year (469 shares)-1,622.211,227.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1622-1632012271217
20-3244-3254024552444
30-4867-4876036823671
40-6489-6498049104898
50-8111-8120061376125
60-9733-9742073657352
70-11355-11364085928579
80-12978-12986098199806
90-14600-1460801104711033
100-16222-1623001227412260

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.035.00.02.8%1.035.00.02.8%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%6.014.00.030.0%11.025.00.030.6%11.025.00.030.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.036.00.0%0.00.036.00.0%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%6.014.00.030.0%11.025.00.030.6%11.025.00.030.6%

Fundamentals of Bone Biologics Corp

About Bone Biologics Corp

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Fundamental data was last updated by Penke on 2024-03-25 17:40:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Bone Biologics Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bone Biologics Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bone Biologics Corp to the Medical Devices industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bone Biologics Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--10.6%+10.6%
TTM--20.2%+20.2%
YOY--14.0%+14.0%
5Y--19.5%+19.5%
10Y--23.8%+23.8%
1.1.2. Return on Assets

Shows how efficient Bone Biologics Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bone Biologics Corp to the Medical Devices industry mean.
  • -41.5% Return on Assets means that Bone Biologics Corp generated $-0.41 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bone Biologics Corp:

  • The MRQ is -41.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -41.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-41.5%TTM-41.6%+0.1%
TTM-41.6%YOY-1.7%-39.8%
TTM-41.6%5Y-4,640.5%+4,598.9%
5Y-4,640.5%10Y-2,663.5%-1,977.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-41.5%-3.0%-38.5%
TTM-41.6%-4.2%-37.4%
YOY-1.7%-4.0%+2.3%
5Y-4,640.5%-3.8%-4,636.7%
10Y-2,663.5%-4.1%-2,659.4%
1.1.3. Return on Equity

Shows how efficient Bone Biologics Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bone Biologics Corp to the Medical Devices industry mean.
  • -53.3% Return on Equity means Bone Biologics Corp generated $-0.53 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bone Biologics Corp:

  • The MRQ is -53.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -72.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-53.3%TTM-72.3%+19.0%
TTM-72.3%YOY1.0%-73.3%
TTM-72.3%5Y-14.4%-57.9%
5Y-14.4%10Y-8.0%-6.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-53.3%-3.5%-49.8%
TTM-72.3%-4.4%-67.9%
YOY1.0%-4.7%+5.7%
5Y-14.4%-5.7%-8.7%
10Y-8.0%-6.2%-1.8%

1.2. Operating Efficiency of Bone Biologics Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bone Biologics Corp is operating .

  • Measures how much profit Bone Biologics Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bone Biologics Corp to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bone Biologics Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--24.5%+24.5%
TTM--14.9%+14.9%
YOY--11.5%+11.5%
5Y--17.1%+17.1%
10Y--20.6%+20.6%
1.2.2. Operating Ratio

Measures how efficient Bone Biologics Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bone Biologics Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.454-1.454
TTM-1.452-1.452
YOY-1.434-1.434
5Y-1.432-1.432
10Y-1.366-1.366

1.3. Liquidity of Bone Biologics Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bone Biologics Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 4.50 means the company has $4.50 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bone Biologics Corp:

  • The MRQ is 4.496. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.585. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.496TTM3.585+0.910
TTM3.585YOY50.231-46.645
TTM3.5855Y14.113-10.527
5Y14.11310Y12.618+1.495
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4962.789+1.707
TTM3.5852.793+0.792
YOY50.2313.586+46.645
5Y14.1133.492+10.621
10Y12.6183.450+9.168
1.3.2. Quick Ratio

Measures if Bone Biologics Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bone Biologics Corp to the Medical Devices industry mean.
  • A Quick Ratio of 4.04 means the company can pay off $4.04 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bone Biologics Corp:

  • The MRQ is 4.036. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.243. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.036TTM3.243+0.793
TTM3.243YOY48.155-44.912
TTM3.2435Y13.628-10.385
5Y13.62810Y10.940+2.688
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0361.587+2.449
TTM3.2431.633+1.610
YOY48.1552.185+45.970
5Y13.6282.300+11.328
10Y10.9402.255+8.685

1.4. Solvency of Bone Biologics Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bone Biologics Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bone Biologics Corp to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.22 means that Bone Biologics Corp assets are financed with 22.2% credit (debt) and the remaining percentage (100% - 22.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bone Biologics Corp:

  • The MRQ is 0.222. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.326. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.222TTM0.326-0.104
TTM0.326YOY0.119+0.207
TTM0.3265Y1,378.182-1,377.856
5Y1,378.18210Y768.862+609.320
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2220.400-0.178
TTM0.3260.386-0.060
YOY0.1190.330-0.211
5Y1,378.1820.440+1,377.742
10Y768.8620.460+768.402
1.4.2. Debt to Equity Ratio

Measures if Bone Biologics Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bone Biologics Corp to the Medical Devices industry mean.
  • A Debt to Equity ratio of 28.6% means that company has $0.29 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bone Biologics Corp:

  • The MRQ is 0.286. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.596. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.286TTM0.596-0.310
TTM0.596YOY0.158+0.438
TTM0.5965Y0.152+0.444
5Y0.15210Y0.084+0.067
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2860.566-0.280
TTM0.5960.569+0.027
YOY0.1580.479-0.321
5Y0.1520.626-0.474
10Y0.0840.692-0.608

2. Market Valuation of Bone Biologics Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bone Biologics Corp generates.

  • Above 15 is considered overpriced but always compare Bone Biologics Corp to the Medical Devices industry mean.
  • A PE ratio of -0.64 means the investor is paying $-0.64 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bone Biologics Corp:

  • The EOD is -0.302. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.641. Based on the earnings, the company is expensive. -2
  • The TTM is -0.294. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.302MRQ-0.641+0.339
MRQ-0.641TTM-0.294-0.347
TTM-0.294YOY-2.205+1.912
TTM-0.2945Y-0.800+0.507
5Y-0.80010Y-0.476-0.324
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.302-1.038+0.736
MRQ-0.641-1.216+0.575
TTM-0.294-1.757+1.463
YOY-2.205-2.582+0.377
5Y-0.800-1.553+0.753
10Y-0.476-1.463+0.987
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bone Biologics Corp:

  • The EOD is -0.232. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.492. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.214. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.232MRQ-0.492+0.260
MRQ-0.492TTM-0.214-0.279
TTM-0.214YOY-2.845+2.631
TTM-0.2145Y-0.966+0.753
5Y-0.96610Y-0.702-0.264
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.232-1.207+0.975
MRQ-0.492-1.746+1.254
TTM-0.214-2.961+2.747
YOY-2.845-6.143+3.298
5Y-0.966-4.928+3.962
10Y-0.702-5.626+4.924
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bone Biologics Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.37 means the investor is paying $1.37 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bone Biologics Corp:

  • The EOD is 0.644. Based on the equity, the company is cheap. +2
  • The MRQ is 1.367. Based on the equity, the company is underpriced. +1
  • The TTM is 0.575. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.644MRQ1.367-0.723
MRQ1.367TTM0.575+0.793
TTM0.575YOY0.810-0.235
TTM0.5755Y0.286+0.289
5Y0.28610Y0.058+0.228
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.6442.038-1.394
MRQ1.3672.321-0.954
TTM0.5752.444-1.869
YOY0.8103.028-2.218
5Y0.2863.918-3.632
10Y0.0584.245-4.187
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bone Biologics Corp.

3.1. Institutions holding Bone Biologics Corp

Institutions are holding 1.263% of the shares of Bone Biologics Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Citadel Advisors Llc0.2652011335113350
2023-12-31Tower Research Capital LLC0.22930.0001122538946.5311
2023-12-31Wells Fargo & Co0.000704133.3333
2023-09-30Kepos Capital LP000-50000-100
2023-09-30Warberg Asset Management LLC000-27000-100
2023-12-31Geode Capital Management, LLC000-2002-100
2023-12-31MML Investors Services Inc000-1875-100
2023-12-31Virtu Financial LLC000-1406-100
2023-12-31Walleye Trading Advisors, LLC000-33775-100
2023-12-31UBS Group AG000-17-100
Total 0.49520.000112564-104350-830.5%

3.2. Funds holding Bone Biologics Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Fidelity Extended Market Index0.37010197700
Total 0.37010197700.0%

3.3. Insider Transactions

Insiders are holding 8.154% of the shares of Bone Biologics Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-09-13Deina H WalshBUY10005.12
2023-09-11Jeff FrelickBUY11875.52
2023-09-06Deina H WalshBUY8755.68
2023-08-31Jeff FrelickBUY9505.28

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Bone Biologics Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.096-0.865+141%-0.179+109%0.654+220%0.092+2182%
Book Value Per Share--3.3063.277+1%4.795-31%-3.004+191%-4.902+248%
Current Ratio--4.4963.585+25%50.231-91%14.113-68%12.618-64%
Debt To Asset Ratio--0.2220.326-32%0.119+87%1378.182-100%768.862-100%
Debt To Equity Ratio--0.2860.596-52%0.158+81%0.152+89%0.084+240%
Dividend Per Share----0%-0%-0%-0%
Eps---1.763-1.519-14%-1.057-40%-0.805-54%-1.856+5%
Free Cash Flow Per Share---2.295-2.029-12%-0.921-60%-0.847-63%-1.030-55%
Free Cash Flow To Equity Per Share---1.6220.468-446%1.605-201%0.736-320%0.498-426%
Gross Profit Margin--1.0001.0000%1.0000%1.025-2%1.014-1%
Intrinsic Value_10Y_max---166.583--------
Intrinsic Value_10Y_min---139.861--------
Intrinsic Value_1Y_max---6.194--------
Intrinsic Value_1Y_min---6.078--------
Intrinsic Value_3Y_max---26.611--------
Intrinsic Value_3Y_min---25.244--------
Intrinsic Value_5Y_max---56.676--------
Intrinsic Value_5Y_min---51.916--------
Market Cap1872644.880-112%3973875.5201981028.756+101%4510601.322-12%1628896.192+144%1582138.046+151%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.644-112%1.3670.575+138%0.810+69%0.286+379%0.058+2268%
Pe Ratio-0.302+53%-0.641-0.294-54%-2.205+244%-0.800+25%-0.476-26%
Price Per Share2.130-112%4.5201.730+161%1.360+232%0.994+355%1.111+307%
Price To Free Cash Flow Ratio-0.232+53%-0.492-0.214-57%-2.845+478%-0.966+96%-0.702+43%
Price To Total Gains Ratio1.016-112%2.1570.636+239%-1.105+151%-0.898+142%-0.477+122%
Quick Ratio--4.0363.243+24%48.155-92%13.628-70%10.940-63%
Return On Assets---0.415-0.416+0%-0.017-96%-46.405+11091%-26.635+6324%
Return On Equity---0.533-0.723+36%0.010-5248%-0.144-73%-0.080-85%
Total Gains Per Share--2.096-0.865+141%-0.179+109%0.654+220%0.092+2182%
Usd Book Value--2906361.0003791165.250-23%5493964.000-47%-4740191.650+263%-5656180.444+295%
Usd Book Value Change Per Share--2.096-0.865+141%-0.179+109%0.654+220%0.092+2182%
Usd Book Value Per Share--3.3063.277+1%4.795-31%-3.004+191%-4.902+248%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.763-1.519-14%-1.057-40%-0.805-54%-1.856+5%
Usd Free Cash Flow---2018015.000-2388976.000+18%-891728.250-56%-902573.000-55%-1013479.833-50%
Usd Free Cash Flow Per Share---2.295-2.029-12%-0.921-60%-0.847-63%-1.030-55%
Usd Free Cash Flow To Equity Per Share---1.6220.468-446%1.605-201%0.736-320%0.498-426%
Usd Market Cap1872644.880-112%3973875.5201981028.756+101%4510601.322-12%1628896.192+144%1582138.046+151%
Usd Price Per Share2.130-112%4.5201.730+161%1.360+232%0.994+355%1.111+307%
Usd Profit---1549885.000-2377773.250+53%173583.250-993%-792104.950-49%-1752503.889+13%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share--2.096-0.865+141%-0.179+109%0.654+220%0.092+2182%
 EOD+2 -6MRQTTM+20 -9YOY+6 -235Y+13 -1710Y+17 -13

4.2. Fundamental Score

Let's check the fundamental score of Bone Biologics Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.302
Price to Book Ratio (EOD)Between0-10.644
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.036
Current Ratio (MRQ)Greater than14.496
Debt to Asset Ratio (MRQ)Less than10.222
Debt to Equity Ratio (MRQ)Less than10.286
Return on Equity (MRQ)Greater than0.15-0.533
Return on Assets (MRQ)Greater than0.05-0.415
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Bone Biologics Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.208
Ma 20Greater thanMa 502.324
Ma 50Greater thanMa 1002.949
Ma 100Greater thanMa 2003.499
OpenGreater thanClose2.040
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets3,738
Total Liabilities831
Total Stockholder Equity2,906
 As reported
Total Liabilities 831
Total Stockholder Equity+ 2,906
Total Assets = 3,738

Assets

Total Assets3,738
Total Current Assets3,738
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 3,027
Net Receivables 329
Inventory -329
Other Current Assets 711
Total Current Assets  (as reported)3,738
Total Current Assets  (calculated)3,738
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities831
Long-term Liabilities0
Total Stockholder Equity2,906
Total Current Liabilities
Accounts payable 361
Other Current Liabilities 471
Total Current Liabilities  (as reported)831
Total Current Liabilities  (calculated)831
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock1
Retained Earnings -80,909
Other Stockholders Equity 83,815
Total Stockholder Equity (as reported)2,906
Total Stockholder Equity (calculated)2,906
+/-0
Other
Capital Stock1
Cash and Short Term Investments 3,027
Common Stock Shares Outstanding 534
Liabilities and Stockholders Equity 3,738
Net Debt -3,027
Net Invested Capital 2,906
Net Working Capital 2,906



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-06-302014-03-312013-12-312013-06-302013-03-312012-12-312012-06-302012-03-312011-12-312011-06-302011-03-312010-12-312010-06-302010-03-312009-12-312009-06-302009-03-312008-12-312008-06-302008-03-31
> Total Assets 
-12
-22
-24
0
0
-40
0
0
0
0
0
0
0
0
-6
0
0
0
0
0
-2,756
3,216
4,413
3,302
2,080
4,622
2,635
1,072
973
1,968
1,140
1,941
796
796
378
2,350
1,041
814
266
249
31
7
1
2
0
7
4
52
6,675
6,094
5,659
5,201
8,495
6,784
7,623
4,976
3,738
3,7384,9767,6236,7848,4955,2015,6596,0946,67552470217312492668141,0412,3503787967961,9411,1401,9689731,0722,6354,6222,0803,3024,4133,216-2,75600000-600000000-4000-24-22-12
   > Total Current Assets 
-12
-22
-24
0
0
-40
0
0
0
0
0
0
0
0
-6
0
0
0
0
0
-2,756
3,204
4,402
3,291
2,074
4,622
2,634
1,072
973
1,968
1,140
1,940
796
796
378
2,350
1,041
814
266
249
31
7
1
2
0
7
4
52
6,675
6,094
5,659
5,201
8,495
6,784
7,623
4,976
3,738
3,7384,9767,6236,7848,4955,2015,6596,0946,67552470217312492668141,0412,3503787967961,9401,1401,9689731,0722,6344,6222,0743,2914,4023,204-2,75600000-600000000-4000-24-22-12
       Cash And Cash Equivalents 
-12
-22
-24
0
0
-40
0
0
0
0
0
0
0
0
-6
0
0
0
0
0
-2,756
2,169
3,167
2,126
1,115
4,221
2,194
688
620
1,612
783
1,622
690
690
305
2,294
955
726
176
202
24
2
0
2
0
2
4
3
6,675
5,815
5,455
5,059
7,538
6,188
7,008
4,453
3,027
3,0274,4537,0086,1887,5385,0595,4555,8156,6753420202242021767269552,2943056906901,6227831,6126206882,1944,2211,1152,1263,1672,169-2,75600000-600000000-4000-24-22-12
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
301
301
301
272
272
272
272
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
580
0
0
0
329
329000580000000000000000000002722722722723013013010000000000000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,035
1,236
1,165
86
100
139
83
81
83
85
46
105
105
73
56
85
88
90
48
7
0
0
0
0
5
0
49
0
279
204
142
957
595
615
524
711
71152461559595714220427904905000074890888556731051054685838183139100861,1651,2361,035000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
11
10
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000006101112000000000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
11
10
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000006101112000000000000000000000
       Other Assets 
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
0
52
0
279
204
142
957
595
615
524
0
052461559595714220427905205000000000000000000000000000000000000000000100
> Total Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,800
5,311
5,500
7,761
7,634
7,950
8,123
9,607
10,238
11,390
12,845
9,191
9,191
9,834
9,525
9,639
10,786
11,122
11,631
11,898
12,471
12,846
13,241
13,692
12,471
14,620
15,178
100
55
71
799
2,548
4,011
1,930
1,183
831
8311,1831,9304,0112,548799715510015,17814,62012,47113,69213,24112,84612,47111,89811,63111,12210,7869,6399,5259,8349,1919,19112,84511,39010,2389,6078,1237,9507,6347,7615,5005,3117,800000000000000000000000
   > Total Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,035
43
58
2,145
2,307
2,305
2,159
3,325
3,637
4,506
5,643
962
962
1,271
525
9,639
10,786
11,122
11,631
578
12,471
12,846
13,241
13,692
12,471
14,620
15,178
100
55
71
799
2,548
4,011
1,930
1,183
831
8311,1831,9304,0112,548799715510015,17814,62012,47113,69213,24112,84612,47157811,63111,12210,7869,6395251,2719629625,6434,5063,6373,3252,1592,3052,3072,14558434,035000000000000000000000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,200
1,564
2,109
2,888
8,230
2,109
600
0
9,000
9,700
10,700
11,200
0
0
0
0
0
11,448
12,491
12,768
0
0
0
0
-784
0
0
0
0
0000-784000012,76812,49111,4480000011,20010,7009,7009,00006002,1098,2302,8882,1091,5641,2000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,200
1,564
8,993
10,090
8,230
8,396
600
0
9,000
9,700
10,700
11,200
0
11,448
11,525
11,600
11,723
11,922
12,491
12,768
0
0
0
0
0
0
0
0
0
00000000012,76812,49111,92211,72311,60011,52511,448011,20010,7009,7009,00006008,3968,23010,0908,9931,5641,2000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
187
283
273
336
227
73
114
225
217
217
260
65
125
518
178
138
43
213
249
400
465
213
84
70
100
55
71
799
888
2,279
1,689
1,103
361
3611,1031,6892,27988879971551007084213465400249213431381785181256526021721722511473227336273283187000000000000000000000000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,035
43
58
1,958
2,024
2,032
1,823
1,823
1,823
1,823
1,823
47
745
411
459
514
568
243
294
536
94
94
0
0
810
2,045
2,339
0
55
71
0
1,659
1,732
241
81
471
471812411,7321,6590715502,3392,045810009494536294243568514459411745471,8231,8231,8231,8231,8232,0322,0241,95858434,035000000000000000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,765
5,268
5,442
5,616
5,327
5,646
5,964
6,282
6,601
6,884
7,202
0
8,230
8,563
9,000
0
0
0
0
11,320
0
0
0
0
2,273
2,129
2,410
0
0
71
799
888
0
0
0
0
000088879971002,4102,1292,273000011,32000009,0008,5638,23007,2026,8846,6016,2825,9645,6465,3275,6165,4425,2683,765000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,230
8,396
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000008,3968,23000000000000000000000000000000000
> Total Stockholder Equity
0
0
-16
0
0
0
0
0
0
0
0
0
0
0
-36
-38
-39
-42
-44
-45
480
-4,584
-898
-2,199
-5,681
-3,012
-5,316
-7,050
-8,634
-8,270
-10,250
-10,904
-8,396
-8,396
-9,456
-7,174
-8,598
-9,972
-10,855
-11,382
-11,868
-12,465
-12,845
-13,239
-13,692
-12,465
-14,616
-15,125
6,575
6,039
5,588
4,402
5,947
2,772
5,693
3,793
2,906
2,9063,7935,6932,7725,9474,4025,5886,0396,575-15,125-14,616-12,465-13,692-13,239-12,845-12,465-11,868-11,382-10,855-9,972-8,598-7,174-9,456-8,396-8,396-10,904-10,250-8,270-8,634-7,050-5,316-3,012-5,681-2,199-898-4,584480-45-44-42-39-38-3600000000000-1600
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
5
0
5
5
5
5
0
0
480
24
29
31
32
38
39
39
39
39
39
39
43
43
4
8
26
28
30
31
31
31
31
31
31
31
31
12
10
10
10
10
15
17
3
3
1
133171510101010123131313131313131302826844343393939393939383231292448000555505000000000000
   Retained Earnings Total Equity0000000000-69,789-69,297000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000-4000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
55,142
55,142
0
0
0
0
0
0
0
0
0
0
000000000055,14255,142000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
25
44
45
46
48
48
50
52
52
55
52
59
20
20
20
20
25
25
-480
9,072
13,643
15,704
20,206
29,843
32,338
34,976
38,271
41,709
38,865
40,738
1,823
50,746
52,443
54,962
54,991
55,022
55,062
55,096
55,142
0
0
0
0
55,142
55,142
55,160
77,041
77,194
77,212
77,245
77,892
78,426
83,129
83,149
83,815
83,81583,14983,12978,42677,89277,24577,21277,19477,04155,16055,14255,142000055,14255,09655,06255,02254,99154,96252,44350,7461,82340,73838,86541,70938,27134,97632,33829,84320,20615,70413,6439,072-48025252020202059525552525048484645442500



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-9,428
Operating Income-9,428-9,428
 
Operating Expense (+$)
Research Development6,908
Selling General Administrative2,520
Selling And Marketing Expenses0
Operating Expense9,4289,428
 
Net Interest Income (+$)
Interest Income2
Interest Expense-0
Other Finance Cost-732
Net Interest Income-730
 
Pretax Income (+$)
Operating Income-9,428
Net Interest Income-730
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,949-9,908
EBIT - interestExpense = 0
-8,949
-8,949
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-8,949
Earnings Before Interest and Taxes (EBITDA)-9,428
 
After tax Income (+$)
Income Before Tax-8,949
Tax Provision-0
Net Income From Continuing Ops-6,505-8,949
Net Income-8,949
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses9,428
Total Other Income/Expenses Net480730
 

Technical Analysis of Bone Biologics Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bone Biologics Corp. The general trend of Bone Biologics Corp is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bone Biologics Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bone Biologics Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 2.2 < 2.73 < 2.8601.

The bearish price targets are: .

Tweet this
Bone Biologics Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bone Biologics Corp. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bone Biologics Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bone Biologics Corp. The current macd is -0.24945328.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bone Biologics Corp price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bone Biologics Corp. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bone Biologics Corp price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Bone Biologics Corp Daily Moving Average Convergence/Divergence (MACD) ChartBone Biologics Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bone Biologics Corp. The current adx is 12.62.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bone Biologics Corp shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Bone Biologics Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bone Biologics Corp. The current sar is 2.47241361.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Bone Biologics Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bone Biologics Corp. The current rsi is 39.21. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Bone Biologics Corp Daily Relative Strength Index (RSI) ChartBone Biologics Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bone Biologics Corp. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bone Biologics Corp price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Bone Biologics Corp Daily Stochastic Oscillator ChartBone Biologics Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bone Biologics Corp. The current cci is -117.47602433.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Bone Biologics Corp Daily Commodity Channel Index (CCI) ChartBone Biologics Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bone Biologics Corp. The current cmo is -23.24407739.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Bone Biologics Corp Daily Chande Momentum Oscillator (CMO) ChartBone Biologics Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bone Biologics Corp. The current willr is -84.50704225.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Bone Biologics Corp Daily Williams %R ChartBone Biologics Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bone Biologics Corp.

Bone Biologics Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bone Biologics Corp. The current atr is 0.31198157.

Bone Biologics Corp Daily Average True Range (ATR) ChartBone Biologics Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bone Biologics Corp. The current obv is 15,242,831.

Bone Biologics Corp Daily On-Balance Volume (OBV) ChartBone Biologics Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bone Biologics Corp. The current mfi is 49.90.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Bone Biologics Corp Daily Money Flow Index (MFI) ChartBone Biologics Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bone Biologics Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-09STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Bone Biologics Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bone Biologics Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.208
Ma 20Greater thanMa 502.324
Ma 50Greater thanMa 1002.949
Ma 100Greater thanMa 2003.499
OpenGreater thanClose2.040
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bone Biologics Corp with someone you think should read this too:
  • Are you bullish or bearish on Bone Biologics Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bone Biologics Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bone Biologics Corp

I send you an email if I find something interesting about Bone Biologics Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Bone Biologics Corp.

Receive notifications about Bone Biologics Corp in your mailbox!